MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-04
DOI
10.1038/s41418-019-0309-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 112PCombination effects of MEK inhibitors with statins on cancer cells
- (2018) M Iizuka-Ohashi et al. ANNALS OF ONCOLOGY
- RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis
- (2018) M. Lee Schmidt et al. CANCER RESEARCH
- FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers HarboringBRAF V600EMutations
- (2018) Lauretta Odogwu et al. ONCOLOGIST
- Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity
- (2018) Elaine Lai Han Leung et al. Cell Death & Disease
- Mutant KRAS promotes malignant pleural effusion formation
- (2017) Theodora Αgalioti et al. Nature Communications
- Survival of pancreatic cancer cells lacking KRAS function
- (2017) Mandar Deepak Muzumdar et al. Nature Communications
- Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
- (2017) Nirakar Rajbhandari et al. Cell Reports
- The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin
- (2017) Kana T. Furukawa et al. Cell Reports
- A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling
- (2016) Sai Krishna Athuluri-Divakar et al. CELL
- YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
- (2016) Ralph Gruber et al. GASTROENTEROLOGY
- Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
- (2016) P. Lito et al. SCIENCE
- Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic
- (2016) Benjamin D. Levine et al. Cell Reports
- Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients
- (2015) Jara M. Baas et al. ANTI-CANCER DRUGS
- Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients
- (2015) J. M. Baas et al. INVESTIGATIONAL NEW DRUGS
- IQGAPs choreograph cellular signaling from the membrane to the nucleus
- (2015) Jessica M. Smith et al. TRENDS IN CELL BIOLOGY
- IQGAP1 selectively interacts with K-Ras but not with H-Ras and modulates K-Ras function
- (2014) Hironori Matsunaga et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors
- (2014) Piro Lito et al. CANCER CELL
- Small GTPase RBJ Mediates Nuclear Entrapment of MEK1/MEK2 in Tumor Progression
- (2014) Taoyong Chen et al. CANCER CELL
- Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
- (2014) Avnish Kapoor et al. CELL
- KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
- (2014) Diane D. Shao et al. CELL
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
- (2014) W. Zhang et al. Science Signaling
- MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer
- (2013) Lanlan Li et al. FEBS LETTERS
- Small molecule inhibition of the KRAS–PDEδ interaction impairs oncogenic KRAS signalling
- (2013) Gunther Zimmermann et al. NATURE
- IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase–driven tumors
- (2013) Katherine L Jameson et al. NATURE MEDICINE
- Sef Downregulation by Ras Causes MEK1/2 to Become Aberrantly Nuclear Localized Leading to Polyploidy and Neoplastic Transformation
- (2012) S. Duhamel et al. CANCER RESEARCH
- Mutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras
- (2011) David Matallanas et al. MOLECULAR CELL
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCPE3 Ligase
- (2010) Chen-Ying Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and Characterization of a General Nuclear Translocation Signal in Signaling Proteins
- (2008) Dana Chuderland et al. MOLECULAR CELL
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development
- (2008) Deborah K. Morrison TRENDS IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search